Search
 

Abbott To Sell $14.7 Bln of Bonds

Deal set to be biggest U.S. fixed-income issue since 2009.

X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.

Abbott Laboratories is planning to sell $14.7 billion of bonds in the largest dollar-denominated offering in more than three years as the drug and medical-device maker prepares to split in two.

Complete your profile to continue reading and get FREE access to Treasury & Risk, part of your ALM digital membership.

Your access to unlimited Treasury & Risk content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical Treasury & Risk information including in-depth analysis of treasury and finance best practices, case studies with corporate innovators, informative newsletters, educational webcasts and videos, and resources from industry leaders.
  • Exclusive discounts on ALM and Treasury & Risk events.
  • Access to other award-winning ALM websites including PropertyCasualty360.com and Law.com.

Already have an account?

Recommended Stories

Covid-19 Impacts on Trade

Nathan Feather |

April activity on a supply chain finance platform indicates how the pandemic is affecting specific industries and regions.

Corporate Audits down 71%

Laura Davison & Allyson Versprille |

New tax audits ground to a halt as the coronavirus pandemic crippled the IRS.

Treasury & Risk

Join Treasury & Risk

Don’t miss crucial treasury and finance news along with in-depth analysis and insights you need to make informed treasury decisions. Join Treasury & Risk now!

  • Free unlimited access to Treasury & Risk including case studies with corporate innovators, informative newsletters, educational webcasts, and resources from industry leaders.
  • Exclusive discounts on ALM and Treasury & Risk events.
  • Access to other award-winning ALM publications including PropertyCasualty360.com and Law.com.

Already have an account? Sign In Now
Join Treasury & Risk

Copyright © 2020 ALM Media Properties, LLC. All Rights Reserved.